Thelansis

Acute Myeloid Leukemia (AML) Market Outlook Thelansis’s “Acute Myeloid Leukemia (AML) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036” covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Acute Myeloid Leukemia (AML) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Acute Myeloid Leukemia (AML) Overview Acute myeloid leukemia (AML) is an aggressive hematologic malignancy driven by the clonal proliferation of poorly differentiated myeloid precursors in the bone marrow and blood. Genomic alterations, including FLT3, NPM1, IDH1/2, and TP53 mutations, disrupt cell differentiation, causing bone marrow failure that presents as fatigue, hemorrhage, and severe infections. Diagnosis rel...

Idiopathic Hypersomnia (IH) Market Outlook Thelansis’s “Idiopathic Hypersomnia (IH) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036” covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Idiopathic Hypersomnia (IH) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Idiopathic Hypersomnia (IH) Overview Idiopathic hypersomnia (IH) is a chronic central hypersomnolence disorder characterised by excessive daytime sleepiness, prolonged non-restorative nocturnal sleep, and severe sleep inertia despite adequate or extended sleep opportunity, occurring without identifiable underlying aetiology or narcolepsy-defining features. The pathophysiology implicates enhanced GABAergic inhibitory to...

Recurrent Vulvovaginal Candidiasis (RVVC) Market Outlook Thelansis’s “Recurrent Vulvovaginal Candidiasis (RVVC) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036” covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Recurrent Vulvovaginal Candidiasis (RVVC) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Recurrent Vulvovaginal Candidiasis (RVVC) Overview Recurrent vulvovaginal candidiasis (RVVC) is defined as four or more symptomatic infections within twelve months, primarily driven by Candida albicans. However, the non-albicans strain Nakaseomyces glabrata (formerly Candida glabrata) is increasingly implicated, carrying a highly azole-resistant susceptibility profile. Pathophy...

Global Hyperammonemia Market Outlook Thelansis’s “Global Hyperammonemia Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report (Top 32 Markets) – 2025 To 2035″ covers disease overview, epidemiology, kidney biopsy cases, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Hyperammonemia treatment modalities options for the 32 markets (North America, Europe, Middle East, Asia Pacific, Africa, South / Latin America). Global Hyperammonemia Overview Hyperammonemia is toxic blood ammonia elevation, most commonly from hepatic dysfunction or urea cycle disorders, impairing neuronal function through astrocyte swelling, glutamine accumulation, and oxidative stress. Symptoms range from confusion, asterixis, and irritability to seizures and coma. Diagnosis requires serum ammonia drawn tourniquet-free and immedi...

Global Eye Pain Market Outlook Thelansis’s “Global Eye Pain Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report (Top 32 Markets) – 2025 To 2035″ covers disease overview, epidemiology, kidney biopsy cases, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Eye Pain treatment modalities options for the 32 markets (North America, Europe, Middle East, Asia Pacific, Africa, South / Latin America). Global Eye Pain Overview Eye pain encompasses sharp, aching, or pressure-like discomfort arising from ocular or periocular structures, driven by corneal irritation, intraocular inflammation, raised pressure, or referred neuropathic signals. Key symptoms include photophobia, redness, tearing, and visual disturbance. Diagnosis relies on slit-lamp examination, tonometry, and fluorescein staining, with IOP elev...

Global Breast Cancer Market Outlook Thelansis’s “Global Breast Cancer Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report (Top 32 Markets) – 2025 To 2035″ covers disease overview, epidemiology, kidney biopsy cases, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Breast Cancer treatment modalities options for the 32 markets (North America, Europe, Middle East, Asia Pacific, Africa, South / Latin America). Global Breast Cancer Overview Breast cancer is the most common malignancy in women worldwide, classified into hormone receptor‑positive (HR+), HER2‑positive, and triple‑negative (TNBC) subtypes. Early‑stage disease is managed with surgery, radiation, and subtype‑specific adjuvant systemic therapy. In advanced disease, precision medicine has transformed care: endocrine therapy plus CDK4/6 inhi...